Stockreport

VolitionRx Shares Up 35% on $13M Milestone Payments From Heska [MarketWatch]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF Epigenetics company VolitionRx said in a securities filing that the payments arose from the successful assay transfer of its Nu.Q Vet Cancer Test onto Heska's Element i [Read more]